Design, synthesis and bioevaluation of novel N-heterocyclic hydroxamic acids as histone deacetylase inhibitors and their antitumor activity study
- 21 October 2024
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 48 (45) , 19144-19166
Abstract
Histone deacetylases (HDACs) represent a particularly intriguing focus in the discovery and advancement of anticancer drugs. In this study, we detail the design, synthesis, and evaluation of novel hydroxamic acids featuring a 1H-benzo[d]imidazole component as potent inhibitors of HDACs and potential anticancer agents. A total of 54 novel compounds were designed and synthesized. Biological assessment revealed that compounds 29c, 31c, and 33c were the most effective inhibitors of HDACs and demonstrated significant potential as anti-cancer agents. Furthermore, compound 31c exhibited a 3-fold higher inhibitory activity against the mixture of HDAC isoforms in HeLa cell nuclear extract compared to the reference compound SAHA. Finally, docking studies on HDAC2 and HDAC6 revealed hydrogen bonds and pi-stacking interactions between hydrophobic and hydrophilic residues on the binding pocket surface, particularly with benzimidazole rings and anilide substituents, which enhance the inhibitory potency of the studied compounds.Keywords
Funding Information
- National Foundation for Science and Technology Development (104.01-2021.08)
This publication has 36 references indexed in Scilit:
- Exploration of certain 1,3-oxazole- and 1,3-thiazole-based hydroxamic acids as histone deacetylase inhibitors and antitumor agentsBioorganic Chemistry, 2020
- Design, synthesis and evaluation of novel N -hydroxybenzamides/ N -hydroxypropenamides incorporating quinazolin-4(3 H )-ones as histone deacetylase inhibitors and antitumor agentsBioorganic Chemistry, 2018
- Exploration of novel 5′(7′)-substituted-2′-oxospiro[1,3]dioxolane-2,3′-indoline-based N -hydroxypropenamides as histone deacetylase inhibitors and antitumor agentsArabian Journal of Chemistry, 2017
- Novel N -hydroxybenzamides incorporating 2-oxoindoline with unexpected potent histone deacetylase inhibitory effects and antitumor cytotoxicityBioorganic Chemistry, 2017
- Histone deacetylase inhibitors (HDACIs). Structure—activity relationships: history and new QSAR perspectivesMedicinal Research Reviews, 2011
- Benzothiazole-containing hydroxamic acids as histone deacetylase inhibitors and antitumor agentsBioorganic & Medicinal Chemistry Letters, 2011
- HDAC family: What are the cancer relevant targets?Cancer Letters, 2009
- HDAC inhibitors: Clinical update and mechanism-based potentialBiochemical Pharmacology, 2007
- Synthesis and cytotoxicity of 2,5-dihydroxychalcones and related compoundsArchives of Pharmacal Research, 2004
- Design of tetrapeptide ligands as inhibitors of the Src SH2 domainBioorganic & Medicinal Chemistry, 2004